Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jul 1;100(1):189–196. doi: 10.1172/JCI119512

Possible evidence for endogenous production of a novel galanin-like peptide.

Z L Wang 1, R N Kulkarni 1, R M Wang 1, D M Smith 1, M A Ghatei 1, P G Byfield 1, W M Bennet 1, S R Bloom 1
PMCID: PMC508179  PMID: 9202071

Abstract

Galanin mRNA and peptide are not detectable in normal islets. We studied the effect of galanin antagonists on insulin secretion in the rat beta cell line, RIN5AH, and in perifused rat islets. In RIN cell membranes galanin and its antagonists showed high affinity for 125I-galanin binding sites [Kd: (galanin) 0.03+/-0.01; Ki for galanin antagonists: (C7) 0.12+/- 0.02, (M35) 0.21+/-0.04, and (M40) 0.22+/-0.03 nM, mean+/- SEM, n = 4]. Galanin (1 microM) inhibited glucose-induced insulin release in islets (control 21.2+/-1.5 vs. galanin 4.5+/-0.2 fmol/islet per min, P < 0.001, n = 6) and RIN5AH cells (control 0.26+/-0.01 vs. galanin 0.15+/-0.02 pmol/10(6) cells per h, P < 0.001, n = 9). In RIN5AH cells, all antagonists blocked the inhibitory effects of galanin and stimulated insulin release in the absence of galanin. C7 and M40 (1 microM) alone significantly stimulated glucose-induced insulin secretion. Purified porcine galanin antibody (GAb) enhanced glucose-induced insulin release from islets (control 100+/- 16.3% vs. GAb 806.1+/-10.4%, P < 0.001, n = 6), and RIN5AH cells (control 100+/-9.6% vs. GAb 149+/-6.8%, P < 0. 01, n = 6). Western blotting of dexamethasone-treated islet extracts using GAb showed a specific band of similar molecular weight to porcine galanin not detected using a rat specific galanin antibody. One possible explanation for these results is the presence of an endogenous galanin-like peptide.

Full Text

The Full Text of this article is available as a PDF (270.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén B., Lindskog S. Galanin and the regulation of islet hormone secretion. Int J Pancreatol. 1992 Jun;11(3):147–160. doi: 10.1007/BF02924180. [DOI] [PubMed] [Google Scholar]
  2. Amiranoff B., Lorinet A. M., Laburthe M. Galanin receptor in the rat pancreatic beta cell line Rin m 5F. Molecular characterization by chemical cross-linking. J Biol Chem. 1989 Dec 5;264(34):20714–20717. [PubMed] [Google Scholar]
  3. Bartfai T., Fisone G., Langel U. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol Sci. 1992 Aug;13(8):312–317. doi: 10.1016/0165-6147(92)90098-q. [DOI] [PubMed] [Google Scholar]
  4. Bartfai T., Langel U., Bedecs K., Andell S., Land T., Gregersen S., Ahrén B., Girotti P., Consolo S., Corwin R. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11287–11291. doi: 10.1073/pnas.90.23.11287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Batra V. K., Mathur M., Mir S. A., Kapoor R., Kumar M. A. Pneumadin: a new lung peptide which triggers antidiuresis. Regul Pept. 1990 Sep 10;30(2):77–87. doi: 10.1016/0167-0115(90)90049-3. [DOI] [PubMed] [Google Scholar]
  6. Bedecs K., Berthold M., Bartfai T. Galanin--10 years with a neuroendocrine peptide. Int J Biochem Cell Biol. 1995 Apr;27(4):337–349. doi: 10.1016/1357-2725(95)00008-d. [DOI] [PubMed] [Google Scholar]
  7. Bhogal R., Smith D. M., Bloom S. R. Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes. Endocrinology. 1992 Feb;130(2):906–913. doi: 10.1210/endo.130.2.1310282. [DOI] [PubMed] [Google Scholar]
  8. Cormont M., Le Marchand-Brustel Y., Van Obberghen E., Spiegel A. M., Sharp G. W. Identification of G protein alpha-subunits in RINm5F cells and their selective interaction with galanin receptor. Diabetes. 1991 Sep;40(9):1170–1176. doi: 10.2337/diab.40.9.1170. [DOI] [PubMed] [Google Scholar]
  9. Crawley J. N., Robinson J. K., Langel U., Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 1993 Jan 15;600(2):268–272. doi: 10.1016/0006-8993(93)91382-3. [DOI] [PubMed] [Google Scholar]
  10. Dunning B. E., Ahren B., Böttcher G., Sundler F., Taborsky G. J., Jr The presence and actions of NPY in the canine endocrine pancreas. Regul Pept. 1987 Sep;18(5-6):253–265. doi: 10.1016/0167-0115(87)90183-2. [DOI] [PubMed] [Google Scholar]
  11. Dunning B. E., Ahren B., Veith R. C., Böttcher G., Sundler F., Taborsky G. J., Jr Galanin: a novel pancreatic neuropeptide. Am J Physiol. 1986 Jul;251(1 Pt 1):E127–E133. doi: 10.1152/ajpendo.1986.251.1.E127. [DOI] [PubMed] [Google Scholar]
  12. Dunning B. E., Ahrén B. Reduced pancreatic content of the inhibitory neurotransmitter galanin in genetically obese, hyperinsulinemic mice. Pancreas. 1992;7(2):233–239. doi: 10.1097/00006676-199203000-00016. [DOI] [PubMed] [Google Scholar]
  13. Dunning B. E., Havel P. J., Veith R. C., Taborsky G. J., Jr Pancreatic and extrapancreatic galanin release during sympathetic neural activation. Am J Physiol. 1990 Mar;258(3 Pt 1):E436–E444. doi: 10.1152/ajpendo.1990.258.3.E436. [DOI] [PubMed] [Google Scholar]
  14. Dunning B. E., Karlsson S., Ahrén B. Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice. Acta Physiol Scand. 1991 Oct;143(2):145–152. doi: 10.1111/j.1748-1716.1991.tb09215.x. [DOI] [PubMed] [Google Scholar]
  15. Dunning B. E., Taborsky G. J., Jr Galanin--sympathetic neurotransmitter in endocrine pancreas? Diabetes. 1988 Sep;37(9):1157–1162. doi: 10.2337/diab.37.9.1157. [DOI] [PubMed] [Google Scholar]
  16. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  17. Gregersen S., Lindskog S., Land T., Langel U., Bartfai T., Ahrén B. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35. Eur J Pharmacol. 1993 Feb 23;232(1):35–39. doi: 10.1016/0014-2999(93)90725-w. [DOI] [PubMed] [Google Scholar]
  18. Hramiak I. M., Dupre J., McDonald T. J. Effects of galanin on insulin responses to hormonal, neuropeptidal, and pharmacological stimuli in conscious dogs. Endocrinology. 1988 Jun;122(6):2486–2491. doi: 10.1210/endo-122-6-2486. [DOI] [PubMed] [Google Scholar]
  19. Jamal H., Jones P. M., Byrne J., Suda K., Ghatei M. A., Kanse S. M., Bloom S. R. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans. Endocrinology. 1991 Dec;129(6):3372–3380. doi: 10.1210/endo-129-6-3372. [DOI] [PubMed] [Google Scholar]
  20. Kaplan L. M., Spindel E. R., Isselbacher K. J., Chin W. W. Tissue-specific expression of the rat galanin gene. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1065–1069. doi: 10.1073/pnas.85.4.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karlsen A. E., Fujimoto W. Y., Rabinovitch P., Dube S., Lernmark A. Effects of sodium butyrate on proliferation-dependent insulin gene expression and insulin release in glucose-sensitive RIN-5AH cells. J Biol Chem. 1991 Apr 25;266(12):7542–7548. [PubMed] [Google Scholar]
  22. Karlsson S., Ahrén B. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism. Metabolism. 1990 Jul;39(7):724–732. doi: 10.1016/0026-0495(90)90108-o. [DOI] [PubMed] [Google Scholar]
  23. Kask K., Berthold M., Bourne J., Andell S., Langel U., Bartfai T. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells. Regul Pept. 1995 Nov 10;59(3):341–348. doi: 10.1016/0167-0115(95)00089-t. [DOI] [PubMed] [Google Scholar]
  24. Kulkarni R. N., Wang Z. L., Akinsanya K. O., Bennet W. M., Wang R. M., Smith D. M., Ghatei M. A., Byfield P. G., Bloom S. R. Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Endocrinology. 1995 Nov;136(11):5155–5164. doi: 10.1210/endo.136.11.7588254. [DOI] [PubMed] [Google Scholar]
  25. Lacy P. E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967 Jan;16(1):35–39. doi: 10.2337/diab.16.1.35. [DOI] [PubMed] [Google Scholar]
  26. Lagny-Pourmir I., Amiranoff B., Lorinet A. M., Tatemoto K., Laburthe M. Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein. Endocrinology. 1989 May;124(5):2635–2641. doi: 10.1210/endo-124-5-2635. [DOI] [PubMed] [Google Scholar]
  27. Leibowitz S. F., Kim T. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res. 1992 Dec 18;599(1):148–152. doi: 10.1016/0006-8993(92)90863-5. [DOI] [PubMed] [Google Scholar]
  28. Lindskog S., Ahrén B., Dunning B. E., Sundler F. Galanin-immunoreactive nerves in the mouse and rat pancreas. Cell Tissue Res. 1991 May;264(2):363–368. doi: 10.1007/BF00313975. [DOI] [PubMed] [Google Scholar]
  29. Lindskog S., Ahrén B., Land T., Langel U., Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol. 1992 Jan 14;210(2):183–188. doi: 10.1016/0014-2999(92)90669-u. [DOI] [PubMed] [Google Scholar]
  30. McDonald T. J., Dupre J., Tatemoto K., Greenberg G. R., Radziuk J., Mutt V. Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes. 1985 Feb;34(2):192–196. doi: 10.2337/diab.34.2.192. [DOI] [PubMed] [Google Scholar]
  31. Montuenga L. M., Martínez A., Miller M. J., Unsworth E. J., Cuttitta F. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology. 1997 Jan;138(1):440–451. doi: 10.1210/endo.138.1.4881. [DOI] [PubMed] [Google Scholar]
  32. Myrsén U., Ahrén B., Sundler F. Dexamethasone-induced neuropeptide Y expression in rat islet endocrine cells. Rapid reversibility and partial prevention by insulin. Diabetes. 1996 Oct;45(10):1306–1316. doi: 10.2337/diab.45.10.1306. [DOI] [PubMed] [Google Scholar]
  33. Ogren S. O., Pramanik A., Land T., Langel U. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release. Eur J Pharmacol. 1993 Sep 21;242(1):59–64. doi: 10.1016/0014-2999(93)90010-f. [DOI] [PubMed] [Google Scholar]
  34. Olmos G., Kulkarni R. N., Haque M., MacDermot J. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Eur J Pharmacol. 1994 Sep 1;262(1-2):41–48. doi: 10.1016/0014-2999(94)90026-4. [DOI] [PubMed] [Google Scholar]
  35. Shimosegawa T., Moriizumi S., Koizumi M., Kashimura J., Yanaihara N., Toyota T. Immunohistochemical demonstration of galaninlike immunoreactive nerves in the human pancreas. Gastroenterology. 1992 Jan;102(1):263–271. doi: 10.1016/0016-5085(92)91809-i. [DOI] [PubMed] [Google Scholar]
  36. Tatemoto K., Rökaeus A., Jörnvall H., McDonald T. J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 1983 Nov 28;164(1):124–128. doi: 10.1016/0014-5793(83)80033-7. [DOI] [PubMed] [Google Scholar]
  37. Timmers K., Coleman D. L., Voyles N. R., Powell A. M., Rökaeus A., Recant L. Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences. Metabolism. 1990 Apr;39(4):378–383. doi: 10.1016/0026-0495(90)90252-8. [DOI] [PubMed] [Google Scholar]
  38. Verge V. M., Xu X. J., Langel U., Hökfelt T., Wiesenfeld-Hallin Z., Bartfai T. Evidence for endogenous inhibition of autotomy by galanin in the rat after sciatic nerve section: demonstrated by chronic intrathecal infusion of a high affinity galanin receptor antagonist. Neurosci Lett. 1993 Jan 12;149(2):193–197. doi: 10.1016/0304-3940(93)90769-h. [DOI] [PubMed] [Google Scholar]
  39. Wang Z. L., Bennet W. M., Ghatei M. A., Byfield P. G., Smith D. M., Bloom S. R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes. 1993 Feb;42(2):330–335. doi: 10.2337/diab.42.2.330. [DOI] [PubMed] [Google Scholar]
  40. Wang Z. L., Bennet W. M., Wang R. M., Ghatei M. A., Bloom S. R. Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. Endocrinology. 1994 Jul;135(1):200–206. doi: 10.1210/endo.135.1.8013354. [DOI] [PubMed] [Google Scholar]
  41. Wynick D., Smith D. M., Ghatei M., Akinsanya K., Bhogal R., Purkiss P., Byfield P., Yanaihara N., Bloom S. R. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4231–4235. doi: 10.1073/pnas.90.9.4231. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES